Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 907-927 , October 2007

Extra-articular manifestations and complications of rheumatoid arthritis

    MD, FRCP
  • Adam Young (Consultant Rheumatologist)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 727 897362; Fax: +1 727 897033.

References 

  1. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. The American Journal of Medicine. 1973;54:445–452
  2. Turesson C, Jacobsson L, Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999;38:668–674
  3. Young A, Dixey J, Cox N, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford). 2000 Jun;39:603–611
  4. Turesson C, Jacobsson L, Bergström U, et al. Predictors of extra-articular manifestations in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2000;29:358–364
  5. Fleming A, Dodman S, Corbett M. Extra-articular features in early rheumatoid arthritis. British Medical Journal. 1976;1:1241–1243
  6. Wilson A, Yu HT, Goodnough LT, Nissenson AR. Prevalence and outcomes of anaemia in rheumatoid arthritis: a systematic review of the literature. The American Journal of Medicine. 2004;116:50S–57S
  7. Symmons D. Lymphoma and rheumatoid arthritis—again. Rheumatology. 2007;46(1):1–2
  8. Van Staa TP, Guesens P, Bijlsma JWJ, et al. Clinical assessment of the long term risk of fracture inpatients with RA. Arthritis and Rheumatism. 2006;54:3104–3112
  9. Myllykangas-Luosujarvi R, Aho K, Isomaki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. The Journal of rheumatology. 1995;22(12):2200–2202
  10. Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2006;45:350–357
  11. Kearney PM, Baigent C, Godwin , et al. Do selective cyto-oxygenase inhibitors and traditional non steroidal anti inflammatory drugs increase risk of athero thrombosis? Meta-analysis of randomised trials. British Journal of Rheumatology. 2006;332:1302–1305
  12. Bonfiglio T, Atwater C. Heart disease in patients with seropositive RA. Archives of internal medicine. 1969;124:714–719
  13. Manzi S, Wasko MCM. Inflammation-mediated rheumatic diseases and atherosclerosis. Annals of the Rheumatic Diseases. 2000;59:321–325
  14. Ridker P, Cushman M, Stampfer M, et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. The New England Journal of Medicine. 1997;973–979
  15. McMahon MJ, Swinson DR, Shettar S, et al. Bronchiectasis and rheumatoid arthritis: a clinical study. Annals of the Rheumatic Diseases. 1993;52:776–779
  16. Turesson C, O'Fallon WM, Crowson CS, et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. The Journal of rheumatology. 2002;29:62–67
  17. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis and Rheumatism. 2003;48:54–58
  18. Voskuyl AE, Zwinderman AH, Westedt ML, et al. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Annals of the Rheumatic Diseases. 1996;55:190–192
  19. Conn DL, McDuffie FC, Dyke PJ. Immunpathological studies of sural nerves in RA. Arthritis and Rheumatism. 1972;15:135–143
  20. Turesson C, McClelland RL, Christianson TJH et al. Incidence and predictors of severe extraarticular disease manifestations in an early RA inception cohort [in press].
  21. Turesson C, McClelland RL, Christianson TJ, Matteson EL. No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis and Rheumatism. 2004;50:3729–3731
  22. Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct?. Rheumatology (Oxford). 2004;43:920–923
  23. Ward MM. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis and Rheumatism. 2004;50:1122–1131
  24. Drosos AA, Lanchbury JS, Panayi GS. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiology and serology study. Arthritis and Rheumatism. 1992;35:745–748
  25. Carmona L, Gonzalez-Alvaro I. Rheumatoid arthritis in Spain:occurrence of extra-articular manifestations and estimates of disease severity. Annals of the Rheumatic Diseases. 2003;62:897–900
  26. Cimmino MA. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatology International. 2000;19:213–217
  27. Salvarani C, Macchioni P, Mantovani W, et al. Extraarticular manifestations of RA and HLA antigens in northern Italy. Rheumatology. 1992;19:242–246
  28. Benazet JF, Reviron D, Mercier P, et al. HLA-DRB1 alleles associated with RA in southern France. Absence of extraarticular disease despite expression of the shared epitope. Rheumatology. 1995;4:607–610
  29. Perdringer A, Chales G, Semana G, et al. Role of HLA-DR-DR & DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factors in RA. Rheumatology. 1997;7:1272–1276
  30. Agrawal S, Dabadghos A, Nach S, Misra R. Compound heterozygosity of HLA-DR4 and DR1 antigens in Asian Indians increases the risk of extra-articular features in RA. British Journal of Rheumatology. 1995;34:41–44
  31. Rycke De, Peene I, Hoffman IE, et al. Rheumatoid Factor and anti CCP ab in RA: diagnostic value, associations with radiological progression rate and extraarticular manifestations. Annals of the Rheumatic Diseases. 2004;12:1587–1593
  32. Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2004;33:65–72
  33. Turesson C, Schaid DJ, Weyand CM, et al. The impact of HLA-DRB1 genes on extra-articular disease manifestations of RA. Arthritis Research & Therapy. 2005;R1386–R1393
  34. Ioannidis JPA, Tarassi K, Papadopoulos IA, et al. Shared epitope and RA: disease associations in Greece and meta-analysis of Mediterranean European populations. Seminars in Arthritis and Rheumatism. 2002;31:361–370
  35. Young A, Corbett M, Jaqueremada D, et al. HLA Antigen Associations with Radiological Changes in the Hands, Feet and Cervical Spines in Early Rheumatoid Arthritis. Disease Markers. 1986;4:133–137
  36. Winfield J, Young A, Williams P, Corbett M. A Prospective Study of the Radiological Changes of Hands, Feet & Cervical Spine in Adult Rheumatoid Disease. Annals of the Rheumatic Diseases. 1983;42:613–618
  37. Jonsson T, Arinbjarnarson S, Thorsteinsson J, et al. Scandinavian Journal of Rheumatology. 1995;24:372–375
  38. Turesson C, Jacobsson LTH, Sturfelt G, et al. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2006;65:1533
  39. Rajasekaran BA, Shovlin D, Lord P, Kelly CA. Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis. Rheumatology (Oxford). 2001;40:1022–1025
  40. Asmussen KH, Bowman SJ. Outcome measures in Sjogrens syndrome. Rheumatology. 2001;40:1085–1088
  41. Bansback NJ, Young A, Brennan A, Dixey J. A prognostic model for functional outcome in early rheumatoid arthritis. The Journal of Rheumatology. 2006;33:8
  42. Young A, Wilkinson P, James D, et al. Socio-economic factors in the presentation and outcome of early rheumatoid arthritis. Lessons for the health service?. Annals of the Rheumatic Diseases. 2000;59:794–799
  43. Kobelt G, Jonsson L, Lindgren P, et al. Modelling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of RA. Arthritis and Rheumatism. 2002;46:2310–2319
  44. Young A, Dixey J, Kulininska E, et al. Which patients with early RA stop working? Results from a 5yr inception cohort of 732 patients. Annals of the Rheumatic Diseases. 2002;61:335–340
  45. James D, Young A, Kulinskaya E, et al. Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1029 patients followed for 5 years. Rheumatology (Oxford). 2004;43:369–376
  46. Dixey J, Young A, Solymossy C, et al. Is it possible to predict radiological damage in early RA? A report on occurrence, progression and prognostic factors for radiological erosions over first 3 years in 860 patients from early RA study (ERAS). The Journal of Rheumatology. 2004;31(supplement 69):48–54
  47. Kelly CA. Rheumatoid arthritis, classic lung disease. Bailliere's Clinical Rhematology. 1993;7:1–16
  48. Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Annals of the Rheumatic Diseases. 2003;62:722–727
  49. Kelly C, Hamilton J. What kills patients with rheumatoid arthritis?. Rheumatology (Oxford). 2007;46:183–184
  50. Voskuyl. AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006;45(supplement 4):iv4–iv7
  51. Turesson C, McClelland RL, Christianson TJH, et al. Severe extra-articular diseasemanifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoidarthritis. Annals of the Rheumatic Diseases. 2007;66:70–75
  52. Solomon DH, Goodson NJ. The Cardiovascular system in Rheumatic Disease: the newest “extra-articular” manifestation?. The Journal of Rheumatology. 2005;32:1415–1417Editorial
  53. Alarcon GS, Kremer JM, Macaluso M, et al. Risk factors for methotrexate lung injury in patients with RA. Methotrexate Lung Study Group. Annals of internal medicine. 1997;127:356–364

PII: S1521-6942(07)00063-0

doi: 10.1016/j.berh.2007.05.007

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 907-927 , October 2007

Article Tools

* Image Usage & Resolution